Crossmark

Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial

Crossref DOI link: https://doi.org/10.1038/s41409-022-01754-y

Published Online: 2022-07-15

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zu, Yingling

Li, Zhen https://orcid.org/0000-0001-7268-4809
Gui, Ruirui https://orcid.org/0000-0002-2981-5487
Liu, Yanyan

Zhang, Yanli

Yu, Fengkuan https://orcid.org/0000-0003-0136-3615
Zhao, Huifang

Fu, Yuewen

Zhan, Xinrong

Wang, Zhongliang

Xing, Pengtao

Wang, Xianjing

Wang, Huili

Zhou, Jian https://orcid.org/0000-0001-8290-3104
Song, Yongping https://orcid.org/0000-0002-4615-7586
Funding

Funding for this research was provided by:

Henan Province Medical Science and Technology Public Relations Plan Province Department joint construction projec

Henan Province Medical Science and Technology Public Relations Plan Province Department joint construction project
License Information

Text and Data Mining valid from 2022-07-15

Version of Record valid from 2022-07-15
More Information

Article History

Received: 23 March 2022

Revised: 16 June 2022

Accepted: 28 June 2022

First Online: 15 July 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below